glp-1 agonist prediabetes GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation Semaglutide, a second-generation GLP-1 receptor

Visible changes in brightness and evenness of skin tone may take several weeks to months, depending on baseline pigmentation, dose, route of administration, and adherence to sun protection. Results are often subtle and natural-looking, and ongoing maintenance may be required to sustain benefits, especially in individuals with high sun exposure

Jouer Skin Barrier Cream Infused with vitamin E, shea butter, and alpha lipoic acid, this soothing cream by Jouer instantly plumps skin for a covet-worthy, youthful glow

doi: 10.1016/j.jdiacomp.2017.05.013 51 Moschovaki FilippidouFKirschAHThelenMKtszeriMArtingerKAringerIet al

These interactions may affect absorption, metabolism, or efficacy of either the GLP-1 or the co-administered drug